These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8518038)
1. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study. Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038 [No Abstract] [Full Text] [Related]
2. High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma. Highley MS; Hill ME; Ziras N; Samandas N; Mason RC; Owen W; Dussek J; Barker S; Harper PG Br J Cancer; 1993 Feb; 67(2):407-8. PubMed ID: 8431376 [No Abstract] [Full Text] [Related]
3. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial. Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023 [TBL] [Abstract][Full Text] [Related]
4. A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study. Whitehead RP; Benedetti JK; Abbruzzese JL; Ardalan B; Goodwin JW; Balcerzak SP; Samlowski WE; Lenz HJ; Macdonald JS Invest New Drugs; 2004 Aug; 22(3):335-41. PubMed ID: 15122082 [TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer. Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B; Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. Rigg A; Cunningham D; Gore M; Hill M; O'Brien M; Nicolson M; Chang J; Watson M; Norman A; Hill A; Oates J; Moore H; Ross P Br J Cancer; 1997; 75(1):101-5. PubMed ID: 9000605 [TBL] [Abstract][Full Text] [Related]
19. Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil. A prospective cohort study. Moehler M; Gutzler F; Steinmann S; Boehme M; Raeth U; Stremmel W; Galle PR; Rudi J Chemotherapy; 2003 May; 49(1-2):85-9. PubMed ID: 12714817 [TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens. Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]